The Bowdish lab has received CFI (Canada Foundation for Innovation) funding for infrastructure for her project “Drug development in a post-antibiotic world”. This infrastructure grant ($350,000) will allow her to build a new tissue culture suite, purchase new molecular biology equipment, upgrade the facilities at the high throughput screening lab and Biophotonics unit, all of which will be required to accommodate her expanding lab and to allow her to discover novel “immunomodulators”, that is drugs that enhance the immune response and fight infectious disease.
See the article on McMaster’s Daily News here and in the Hamilton Spectator here.